Palatin Technologies Inc (PTN): Net Income
-$17.31M
Year ended 2025-06-30
-$6.25M
Trailing 12 months to 2026-03-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | -$17.31M | n/m | 2025-09-23, From 2024-07-01 |
| 2024-06-30 | -$29.74M | n/m | 2025-09-23, From 2023-07-01 |
| 2023-06-30 | -$24.04M | n/c | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | -$36.20M | n/m | 2023-09-28, From 2021-07-01 |
| 2021-06-30 | -$33.60M | n/m | 2022-09-22, From 2020-07-01 |
| 2020-06-30 | -$22.43M | n/m | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | $35.77M | +44.8% | 2020-09-25, From 2018-07-01 |
| 2018-06-30 | $24.70M | 0.0% | 2020-09-25, From 2017-07-01 |
| 2017-06-30 | $24.70M | n/c | 2020-09-25, From 2016-07-01 |
| 2016-06-30 | -$51.71M | n/m | 2018-09-13, From 2015-07-01 |
| 2015-06-30 | -$17.67M | n/m | 2017-09-25, From 2014-07-01 |
| 2014-06-30 | -$13.93M | n/m | 2016-09-19, From 2013-07-01 |
| 2013-06-30 | -$20.86M | n/m | 2015-09-18, From 2012-07-01 |
| 2012-06-30 | -$17.25M | n/m | 2014-09-12, From 2011-07-01 |
| 2011-06-30 | -$12.82M | n/m | 2013-09-27, From 2010-07-01 |
| 2010-06-30 | -$1.79M | n/a | 2012-09-10, From 2009-07-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Palatin Technologies Inc (PTN) | 2025-06-30 | -$17.31M | n/m |
| Abbott Laboratories (ABT) | 2025-12-31 | $6.52B | -51.3% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $7.05B | n/m |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | -$569.0K | n/m |
| Eli Lilly & Co (LLY) | 2025-12-31 | $20.64B | +94.9% |
| Pfizer Inc (PFE) | 2025-12-31 | $7.77B | -3.2% |
| Johnson & Johnson (JNJ) | 2025-12-28 | $26.80B | +90.6% |
| Nature's Sunshine Products Inc (NATR) | 2025-12-31 | $20.45M | +159.1% |
| Merck & Co., Inc. (MRK) | 2025-12-31 | $18.25B | +6.6% |
Compare PTN, ABT, BMY, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗